Tradestie Institutional Equity Comparison Engine
VOR vs CGEN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CGEN Overall Edge
CGEN Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Compugen Ltd (CGEN) driven by superior Valuation, Growth & Margin while VOR counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, VOR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CGEN at 12.4x Forward P/E and 41.3% operating margin (+102.1% YoY). In options structure, VOR sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro) against CGEN sits in BREAKDOWN (57th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
CGEN
VOR N/M vs CGEN 12.4x Fwd P/E
Growth & Margin Winner
CGEN
Op Margin 0.0% vs 41.3% ยท YoY +0.0% vs +102.1%
Momentum & Technical Winner
VOR
1Y +81.6% vs +23.2% ยท 52W Pos 60% vs 33%
Options & Structure Winner
VOR
BREAKDOWN (7th %ile IV) vs BREAKDOWN (57th %ile IV)
VOR
NASDAQ
Vor Biopharma Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$18.18
-4.16% 1D
Market Cap
$1.2B
1M Return
+0.78%
1Y Return
+81.62%
Forward P/E
N/M
Unified AI Score
51.5 / 100
HOLD
Tech 22.0
Fund 47.0
Flow 66.0
Mom 50.0
CGEN
NASDAQ
Compugen Ltd
Biological Products, (No Diagnostic Substances)
$2.02
-0.98% 1D
Market Cap
$193.2M
1M Return
+2.54%
1Y Return
+23.17%
Forward P/E
12.4x
Unified AI Score
49.8 / 100
HOLD
Tech 53.0
Fund 52.0
Flow 55.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
VOR +81.62%
CGEN +23.17%
Spread: +58.45 pp (VOR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
VOR TTM Op. Margin: 0.0%
CGEN TTM Op. Margin: 41.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VOR vs CGEN. Trailing 12-month operating profitability (VOR 0.0% vs CGEN 41.3%) and valuation multiples (VOR N/M vs CGEN 12.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VOR | CGEN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | $193.2M | Larger Scale | VOR |
| Trailing P/E Ratio Valuation | 0.1x | 5.2x | Lower Multiple | VOR |
| Forward P/E Ratio Valuation | N/M | 12.4x | Lower Multiple | CGEN |
| Revenue Growth (YoY) Growth | +0.0% | +102.1% | Higher Growth | CGEN |
| Operating Margin (TTM) Profitability | 0.0% | 41.3% | Higher Margin | CGEN |
| Net Profit Margin Profitability | 0.0% | 47.9% | Higher Margin | CGEN |
| Return on Equity (ROE) Capital Efficiency | -125.4% | 57.2% | Higher ROE | CGEN |
| 52-Week Range Position Momentum | 60% ($6โ$26) | 33% ($1โ$3) | Stronger Trend | VOR |
| Beta / 30D Volatility Risk Regime | 1.94ฮฒ ยท 63% Vol | 1.44ฮฒ ยท 62% Vol | Lower Realized Risk | CGEN |
| Unified Institutional Score Composite Signal | 51.5 / 100 (HOLD) | 49.8 / 100 (HOLD) | Higher Composite | VOR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full VOR vs CGEN Buy Guide
VOR
BREAKDOWN
53d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
CGEN
BREAKDOWN
143d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
57th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither VOR nor CGEN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.